Literature DB >> 1936788

Histological maturity of healed duodenal ulcers and ulcer recurrence after treatment with colloidal bismuth subcitrate or cimetidine.

S A Pan1, C H Liao, G S Lien, S H Chen.   

Abstract

The relationship between histological maturity of healed duodenal ulcers and ulcer recurrence after 6 weeks of treatment with colloidal bismuth subcitrate or cimetidine was investigated. There was no significant difference in healing rates between colloidal bismuth subcitrate- and cimetidine-treated patients (85.7% and 71.8%, respectively; P greater than 0.05). Histologically, the regenerating mucosa of healed ulcers was divided into three categories--good, fair, and poor--according to pattern. Sixty percent of healed colloidal bismuth subcitrate-treated and 30.9% of healed cimetidine-treated ulcers had a good pattern; the difference was statistically significant (P = 0.027). The difference in recurrence rates between healed colloidal bismuth subcitrate-treated and healed cimetidine-treated patients was statistically significant at 3 months (3.45% and 20%, respectively; P = 0.044). All recurrent ulcers in both groups had fair or poor patterns of regenerating mucosa. It was concluded that the greater histological maturity of the regenerating mucosa may contribute to the lower recurrence rate in colloidal bismuth subcitrate-treated patients than in cimetidine-treated patients.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936788     DOI: 10.1016/0016-5085(91)90066-t

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

Review 1.  Formulary management of antiulcer drugs: clinical considerations.

Authors:  S L Sankey; L S Friedman
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

2.  Deformity of duodenal bulb, gastric metaplasia of duodenal regenerating mucosa and recurrence of duodenal ulcer: a correlated study.

Authors:  Chun-Chao Chang; Shiann Pan; Gi-Shih Lien; Cheng-Hsiung Liao; Sheng-Hsuan Chen; Yeong-Shan Cheng
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

3.  Indomethacin treatment during initial period of acetic acid-induced rat gastric ulcer healing promotes persistent polymorphonuclear cell-infiltration and increases future ulcer recurrence. Possible mediation of prostaglandins.

Authors:  T Arakawa; T Watanabe; T Fukuda; K Higuchi; O Takaishi; K Yamasaki; K Kobayashi; A Tarnawski
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

4.  Acceleration of wound healing in gastric ulcers by local injection of neutralising antibody to transforming growth factor beta 1.

Authors:  H Ernst; P Konturek; E G Hahn; T Brzozowski; S J Konturek
Journal:  Gut       Date:  1996-08       Impact factor: 23.059

5.  Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.

Authors:  Li-Ying Feng; Xi-Xian Yao; Shu-Lin Jiang
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

6.  Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.

Authors:  C J Hawkey; J Naesdal; I Wilson; G Långström; A J Swannell; R A Peacock; N D Yeomans
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

7.  Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine.

Authors:  T Arakawa; T Watanabe; T Fukuda; K Yamasaki; K Kobayashi
Journal:  Dig Dis Sci       Date:  1995-11       Impact factor: 3.199

8.  Efficacy and safety of Hou Gu Mi Xi for peptic ulcer diseases: Study protocol for a randomized controlled trial.

Authors:  Xiaofan Chen; Dongmei Yan; Jianhe Fang; Wenjun Liu; Heyun Nie; Nonghua Lv; Nian Fang; Jinhua Gong; Jianwei Yu; Yiping Jiang; Zhijun Liu; Huihu Gan; Ying Fu; Deping Yang; Yan Xiong; Dunju Liu; Ming Chen; Yanping Wang; Yang Wang; Xin Sun; Xu Zhou; Weifeng Zhu
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.